HIL Applied Medical

Ultra-compact Proton Beam Systems for Cancer Therapy

Health Tech & Life Sciences
Non Active, Dec 2023 ceased to operate

Company Overview

Snapshot

Founded in November 2010 by Arie Zigler, HIL Applied Medical operates with 11–50 employees. The company has raised $36.82M across 12 funding rounds with 4 investors. In January 2022, HIL Applied Medical and Proton International were awarded a $900K grant from the BIRD Foundation to advance an ultra-compact, affordable proton beam therapy solution for cancer.

Business overview

HIL Applied Medical develops ultra-compact, high-performance accelerators for proton therapy, utilizing a patented, laser-based, nanotech-enabled approach to particle acceleration. This technology aims to facilitate cost-effective, single-room proton therapy systems. The company also focuses on ultra-compact beam delivery solutions, including beamlines and rotating gantries, designed to leverage the unique properties of laser-accelerated proton beams. HIL Applied Medical's technology enables expandable, add-on single-room solutions with clinical capabilities such as 360-degree rotation, integrated imaging, pencil-beam scanning, IMPT, gating, and adaptive therapy, serving the health tech and life sciences sector.

Strategic signal

In January 2022, HIL Applied Medical, in collaboration with Proton International, secured a $900K grant from the BIRD Foundation. This funding is a significant validation of their efforts to develop an ultra-compact and affordable proton beam therapy solution for cancer, signaling a continued focus on innovation and accessibility in cancer treatment technologies.

Company Intelligence Q&A

What is HIL Applied Medical's primary focus?
HIL Applied Medical is focused on developing ultra-compact, high-performance accelerators for proton therapy, utilizing a patented, laser-based, nanotech-enabled approach to particle acceleration.
When was HIL Applied Medical founded?
HIL Applied Medical was founded in November 2010.
What was a significant grant received by HIL Applied Medical?
In January 2022, HIL Applied Medical and Proton International were awarded a $900K grant from the BIRD Foundation to advance an ultra-compact, affordable proton beam therapy solution for cancer.
Has HIL Applied Medical made any acquisitions?
In May 2016, HIL Applied Medical acquired Nanolabz.
What is the status of HIL Applied Medical?
HIL Applied Medical is Non Active, having ceased to operate in December 2023.

External links